Research reveals that the manufacturing cost of Ozempic is significantly lower than its selling price of $1,000 per month. The study emphasizes the excessive pricing of GLP-1 drugs like Ozempic, impacting patients' access due to affordability issues in the US market.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.